Skip to main content

Peer Review reports

From: Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial

Original Submission
14 Feb 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 Mar 2024 Author responded Author comments - Graham McIlroy
Resubmission - Version 3
8 Mar 2024 Submitted Manuscript version 3
12 Mar 2024 Editorially accepted
25 Mar 2024 Article published 10.1186/s12885-024-12112-0

You can find further information about peer review here.

Back to article page